Quest Diagnostics DGX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.9B+3.2% | $2.81B-0.4% | $2.82B+2.0% | $2.76B+4.1% | $2.65B+1.2% | ||
| $1.95B+3.0% | $1.9B+1.6% | $1.87B+2.7% | $1.82B+1.6% | $1.79B+1.5% | ||
| $942M+3.5% | $910M-4.1% | $949M+0.6% | $943M+9.3% | $863M+0.6% | ||
| 32.5%+0.1pp | 32.4%-1.3pp | 33.7%-0.5pp | 34.2%+1.6pp | 32.5%-0.2pp | ||
| $504M0.0% | $504M+0.6% | $501M+3.1% | $486M+2.1% | $476M+2.1% | ||
| $37M0.0% | $37M-5.1% | $39M0.0% | $39M0.0% | $39M+5.4% | ||
| -$2M-112% | $17M+174% | -$23M-215% | $20M+1,100% | -$2M— | ||
| $2.5B+3.1% | $2.42B-0.4% | $2.43B+4.6% | $2.32B+0.7% | $2.31B+2.0% | ||
| $399M+3.4% | $386M0.0% | $386M-11.9% | $438M+26.6% | $346M-4.2% | ||
| 13.8%0.0pp | 13.8%0.0pp | 13.7%-2.2pp | 15.9%+2.8pp | 13%-0.7pp | ||
| -$63M+1.6% | -$64M+3.0% | -$66M+1.5% | -$67M0.0% | -$67M-3.1% | ||
| -$65M-16.1% | -$56M+3.4% | -$58M-7.4% | -$54M+22.9% | -$70M-12.9% | ||
| $4M-42.9% | $7M-12.5% | $8M-11.1% | $9M-50.0% | $18M+260% | ||
| $334M+1.2% | $330M+0.6% | $328M-14.6% | $384M+39.1% | $276M-7.7% | ||
| $74M-8.6% | $81M+5.2% | $77M-20.6% | $97M+64.4% | $59M-13.2% | ||
| $252M+2.9% | $245M0.0% | $245M-13.1% | $282M+28.2% | $220M-0.9% | ||
| 8.7%0.0pp | 8.7%0.0pp | 8.7%-1.5pp | 10.2%+1.9pp | 8.3%-0.2pp | ||
| $2.24+2.8% | $2.18+0.9% | $2.16-12.6% | $2.47+27.3% | $1.94-0.5% | ||
| $2.27+2.7% | $2.21+1.4% | $2.18-13.1% | $2.51+27.4% | $1.97-0.5% | ||
| 112M— | —— | 113M0.0% | 113M0.0% | 113M— | ||
| 110M— | —— | 112M0.0% | 112M+0.9% | 111M— | ||
| -$63M+1.6% | -$64M+3.0% | -$66M+1.5% | -$67M0.0% | -$67M-3.1% | ||
| $37M0.0% | $37M-5.1% | $39M0.0% | $39M0.0% | $39M+5.4% | ||
| -$2M-125% | $8M0.0% | $8M-38.5% | $13M+533% | -$3M-200% | ||
| -$2M-112% | $17M+174% | -$23M-215% | $20M+1,100% | -$2M— | ||
| $2.9B+3.2% | $2.81B-0.4% | $2.82B+2.0% | $2.76B+4.1% | $2.65B+1.2% | ||
| $546M+2.8% | $531M+0.6% | $528M-9.1% | $581M+19.5% | $486M-2.0% | ||
| 18.9%-0.1pp | 18.9%+0.2pp | 18.8%-2.3pp | 21%+2.7pp | 18.3%-0.6pp | ||
| $399M+3.4% | $386M0.0% | $386M-11.9% | $438M+26.6% | $346M-4.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Quest Diagnostics's revenue?
- Quest Diagnostics (DGX) generated $11.3B in revenue over the trailing twelve months, up 11.0% year over year.
- Is Quest Diagnostics profitable?
- Quest Diagnostics reported $1.0B in net income over the trailing twelve months, a 9.1% net margin.
- What are Quest Diagnostics's profit margins?
- Gross margin is 33.2% and operating margin is 14.3%, with a 9.1% net margin.
- What is Quest Diagnostics's earnings per share?
- Quest Diagnostics's diluted EPS over the trailing twelve months is $9.05.
- Where does Quest Diagnostics's income statement data come from?
- Every line is extracted from Quest Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
